Your gift is 100% tax deductible.
Treating HIV-Associated Lymphoma
People with HIV infections are at increased risk for non-Hodgkin lymphoma.
In the past, the outlook for people with HIV-associated lymphoma depended largely on their HIV infection. Now that HIV can usually be well controlled with antiretroviral therapy (ART), the outlook depends more on the type and stage of the lymphoma. Many people with HIV-associated lymphoma can be cured.
What types of lymphoma are associated with HIV?
People with HIV infections tend to get more aggressive forms of non-Hodgkin lymphoma (NHL), such as:
Some less common types of lymphoma are seen mostly in people with HIV. These include:
- Plasmablastic lymphoma
- Primary effusion lymphoma
How has the outlook changed in recent years?
The outlook for people with HIV-associated lymphoma has improved a great deal in recent years, even though people with HIV infections tend to get more aggressive forms of NHL.
Antiretroviral therapy (ART) that is used to treat HIV has helped people better handle lymphoma treatments such as chemotherapy (chemo) and immunotherapy.
Common treatments
Today, people with HIV-associated lymphoma usually get the same kinds of treatment as people without HIV. For example, treatment might involve chemo combined with the monoclonal antibody rituximab.
Common regimens include R-CHOP and DA-EPOCH-R.
If the lymphoma comes back after treatment, you might still be able to get a stem cell transplant or CAR T-cell therapy if your HIV is well controlled.
Taking HIV medicines during lymphoma treatment
Most people continue taking their HIV medicines during lymphoma treatment. This helps keep the HIV under control and helps your immune system recover.
Some HIV medicines can interact with chemo, so your cancer care team may change your HIV medicines during treatment.
Monitoring blood counts and preventing infections
In the past, people with HIV tended to have low blood cell counts to begin with. This was a major problem, because it made it hard to use full doses of chemo for lymphoma treatment.
This problem has improved with ART and drugs that help the body make new blood cells. However, doctors give chemo cautiously and monitor blood counts closely.
You may also get medicines to help prevent infections during treatment.
Learn more
The exact type of treatment you get will depend on your type of lymphoma. For more on how specific types of NHL are treated, see Treating B-Cell Non-Hodgkin Lymphomas.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Barta SK, Xue X, Wang D, et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013;122(19):3251-3262.
Roschewski M, Dunleavy K, Abramson JS, et al. Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma. J Clin Oncol. 2020;38(22):2519-2529.
Sparano JA, Lee JY, Kaplan LD, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2010;115(15):3008-3016.
Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034. Leuk Lymphoma. 2018;59(8):1851-1860.
Last Revised: October 25, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


